Clinton Brokers Generic AIDS Drug Deal
Make a commentBy Ed Silverman // May 8th, 2007 // 2:27 pm
Former President Bill Clinton announced deals with two Indian generic drug companies today to cut prices for second line anti-retroviral AIDS drugs for developing countries. The new prices will mean an average savings of 25 percent in low-income countries and 50 percent in middle-income countries, says Bill.
The pact between the Clinton Foundation and Cipla and Matrix Laboratories covers 66 countries in Africa, Asia, Latin America and the Caribbean.
Source: Reuters[tags]AIDS, Bill Clinton, Cipla, Generics, Matrix Laboratories[/tags]